Aspeya: A new name for science, insight, and innovation March 04, 2025 March 4, 2025 Stamford, CT – March 4, 2025 – We are excited to announce that Vectura Fertin Pharma, Inc. has formally transitioned to a new corporate identity, Aspeya, Inc. Read the article
Vectura Fertin Pharma announces Agreement for Sale of Vectura Group to Molex September 17, 2024 STAMFORD, CT—SEPT. 17, 2024—Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE: PM), [...] Read the article
Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge September 09, 2024 STAMFORD, CT—SEPT. 17, 2024—Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE: PM), [...] Read the article
Aurora Cannabis and Vectura Fertin Pharma announce commercial collaboration August 01, 2024 STAMFORD, CT—SEPT. 17, 2024—Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE: PM), [...] Read the article
